MAP1LC3B and pulmonary arterial hypertension: Human lung tissue isolated from patients with pulmonary hypertension (PH) of various etiologies, including PAH, displayed increases in the total expression of LC3B, and in the levels of its activated (PE-conjugated) form LC3B-II, when compared to lung tissue from patients free of pulmonary vascular disease.